← Back to Search

Behavioural Intervention

Reflux Band for Acid Reflux

N/A
Recruiting
Led By Rena Yadlapati, MD, MSHS
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current use of double daily dose acid suppression therapy (ex. omeprazole 40mg, omeprazole 20mg and famotidine 20mg)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will test a device to help people with laryngopharyngeal reflux, a type of acid reflux. The device, called the Reflux Band, is worn around the neck and compresses the upper esophageal sphincter to prevent reflux. The trial will enroll subjects with salivary pepsin positive LPR and will be double blind, meaning that neither the subjects nor the researchers will know who is in the control or experimental groups. The primary hypothesis is that a significantly higher proportion of subjects in the experimental arm will meet the primary endpoint for symptom response, compared to subjects in the control arm

Who is the study for?
This trial is for adults aged 18-99 with laryngopharyngeal reflux confirmed by tests, who have been on double dose acid suppression therapy. They must not have had neck cancer/surgery, use certain night-time breathing aids, or have specific conditions like glaucoma or a history of foregut surgery. Pregnant/breastfeeding individuals and those unable to consent in English/Spanish are excluded.Check my eligibility
What is being tested?
The study compares an external device that compresses the upper esophageal sphincter (Reflux Band) against a sham device over 12 weeks to see if it reduces symptoms of acid reflux more effectively. Participants will be randomly assigned to either the real treatment or placebo without knowing which one they receive.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site where the Reflux Band is applied, possible interference with neck implants like pacemakers if present, and general risks associated with wearing external compression devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently taking a high dose of acid suppression medication daily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure response to the UES Compression Device in pepsin positive LPR.
Secondary outcome measures
Measure pepsin response to the UES Compression Device in pepsin positive LPR.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ExperimentalExperimental Treatment1 Intervention
Participants allocated to the experimental arm will be fit with the UES Compression Device according to manufacturer guidelines.
Group II: ControlPlacebo Group1 Intervention
Participants allocated to the control arm will be fit with the UES Compression Device at a pressure known not to provide intervention.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,520,852 Total Patients Enrolled
1 Trials studying Laryngopharyngeal Reflux
43 Patients Enrolled for Laryngopharyngeal Reflux
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,520 Total Patients Enrolled
Rena Yadlapati, MD, MSHSPrincipal Investigator - UC San Diego Health
University of California, San Diego

Media Library

Reflux Band (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04827355 — N/A
Laryngopharyngeal Reflux Research Study Groups: Control, Experimental
Laryngopharyngeal Reflux Clinical Trial 2023: Reflux Band Highlights & Side Effects. Trial Name: NCT04827355 — N/A
Reflux Band (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04827355 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment open for this clinical investigation?

"A review of clinicaltrials.gov reveals that this research initiative, first posted on May 7th 2021, is presently recruiting volunteers. This trial was last modified in November 2022."

Answered by AI

Are there certain prerequisites that must be met in order to participate in this research trial?

"This research is actively seeking 72 participants between 18-99 years old who suffer from regurgitation, gastric issues. Key qualifications include: being an adult aged 18-99, English or Spanish fluency, regular usage of double dose PPI*, laryngoscopic exam within the last year with a reflux score higher than 7, elevated reflux testing results and fasting pepsin analysis result ≥25 ng/mL (within 4 months or 12 if treatment plan has been changed)*, 8+ weeks suffering from dysphonia, throat clearing, coughs etc., findings on upper endoscopy that are indicative of pathological GERD."

Answered by AI

Does this research endeavor accept individuals older than twenty years of age?

"This trial is only open to individuals between 18 and 99 years old; for minors or seniors, there are 15 and 53 studies respectively."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
University of California, San Diego

Why did patients apply to this trial?

Recent research and studies
~29 spots leftby Apr 2026